In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

Published Date: 20 Mar 2024

Breast cancer that manifests in between two screening program reviews is known as interval breast cancer. In other words, a negative test result precedes the next evaluation and the diagnosis is made after that. It is very trustworthy for obvious reasons.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early palliative care billing up from 2010 to 2019 for advanced cancer

2.

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

3.

FDA Approves Hemophilia B Second Gene Therapy.

4.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

5.

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot